BiotechTube
Home/Regenesis/Tom Eisiminger, Jr.
TE

Tom Eisiminger, Jr.

President & Chief Executive Officer

Regenesis

Therapeutic Areas

Chronic PainMusculoskeletal DisordersDiabetic Neuropathy

Regenesis Pipeline

DrugIndicationPhase
Reprieve for Diabetic Peripheral NeuropathyDiabetic Peripheral Neuropathy PainPost-Market
Reprieve for Plantar FasciitisPlantar Fasciitis PainPost-Market
Reprieve for Musculoskeletal PainGeneral Musculoskeletal Pain (e.g., Lumbar)Post-Market

Leadership Team at Regenesis

SS
Scott Steinman
Vice President and Chief Financial Officer
ET
Erica Tassone, PhD
Vice President, Research & Development
MR
Mary Ritz, PhD
Co-Founder, former President & CEO
FG
Frank George, PhD
Co-Founder
View full Regenesis profile